NCT03580902View on ClinicalTrials.gov

CBT4CBT for Office Based Buprenorphine

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

January 22, 2019

Primary Completion Date

November 23, 2021

Study Completion Date

August 1, 2022

Conditions
Opioid-use Disorder
Interventions
BEHAVIORAL

CBT4CBT-Buprenorphine

Computerized, user-driven cognitive-behavioral therapy (CBT) web-based program adapted for use in office based buprenorphine treatment

DRUG

Buprenorphine/naloxone

Standard outpatient buprenorphine maintenance

Trial Locations (1)

06511-5991

Central Medical Unit of the APT Foundation, New Haven

All Listed Sponsors
lead

CBT4CBT, LLC

INDUSTRY

NCT03580902 - CBT4CBT for Office Based Buprenorphine | Biotech Hunter | Biotech Hunter